NasdaqGS:KNSABiotechs
Kiniksa’s Heart’s Home Campaign Targets ARCALYST Growth In Pericarditis Market
Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis.
The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis.
Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model.
Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...